246 related articles for article (PubMed ID: 38110878)
21. Lung Microbiota of Critically Ill Patients with COVID-19 Are Associated with Nonresolving Acute Respiratory Distress Syndrome.
Kullberg RFJ; de Brabander J; Boers LS; Biemond JJ; Nossent EJ; Heunks LMA; Vlaar APJ; Bonta PI; van der Poll T; Duitman J; Bos LDJ; Wiersinga WJ;
Am J Respir Crit Care Med; 2022 Oct; 206(7):846-856. PubMed ID: 35616585
[No Abstract] [Full Text] [Related]
22. Dysbiosis of Gut Microbiota and Short-Chain Fatty Acids in Acute Ischemic Stroke and the Subsequent Risk for Poor Functional Outcomes.
Tan C; Wu Q; Wang H; Gao X; Xu R; Cui Z; Zhu J; Zeng X; Zhou H; He Y; Yin J
JPEN J Parenter Enteral Nutr; 2021 Mar; 45(3):518-529. PubMed ID: 32473086
[TBL] [Abstract][Full Text] [Related]
23. Dysbiosis of Gut Microbiota and Short-Chain Fatty Acids in Encephalitis: A Chinese Pilot Study.
Xu R; Tan C; He Y; Wu Q; Wang H; Yin J
Front Immunol; 2020; 11():1994. PubMed ID: 32973805
[TBL] [Abstract][Full Text] [Related]
24. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
[No Abstract] [Full Text] [Related]
25. Fecal microbiota transplantation and short-chain fatty acids reduce sepsis mortality by remodeling antibiotic-induced gut microbiota disturbances.
Lou X; Xue J; Shao R; Yang Y; Ning D; Mo C; Wang F; Chen G
Front Immunol; 2022; 13():1063543. PubMed ID: 36713461
[TBL] [Abstract][Full Text] [Related]
26. Gut Dysbiosis Associated with Antibiotics and Disease Severity and Its Relation to Mortality in Critically Ill Patients.
Ojima M; Shimizu K; Motooka D; Ishihara T; Nakamura S; Shintani A; Ogura H; Iida T; Yoshiya K; Shimazu T
Dig Dis Sci; 2022 Jun; 67(6):2420-2432. PubMed ID: 33939152
[TBL] [Abstract][Full Text] [Related]
27. Associations between Diet, the Gut Microbiome, and Short-Chain Fatty Acid Production among Older Caribbean Latino Adults.
Maldonado-Contreras A; Noel SE; Ward DV; Velez M; Mangano KM
J Acad Nutr Diet; 2020 Dec; 120(12):2047-2060.e6. PubMed ID: 32798072
[TBL] [Abstract][Full Text] [Related]
28. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
Chen R; Wang J; Zhan R; Zhang L; Wang X
J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
[TBL] [Abstract][Full Text] [Related]
29. The relationship between gut microbiota and short chain fatty acids in the renal calcium oxalate stones disease.
Liu Y; Jin X; Hong HG; Xiang L; Jiang Q; Ma Y; Chen Z; Cheng L; Jian Z; Wei Z; Ai J; Qi S; Sun Q; Li H; Li Y; Wang K
FASEB J; 2020 Aug; 34(8):11200-11214. PubMed ID: 32645241
[TBL] [Abstract][Full Text] [Related]
30. Matrix Effects on the Delivery Efficacy of Bifidobacterium animalis subsp.
Ba Z; Lee Y; Meng H; Kris-Etherton PM; Rogers CJ; Lewis ZT; Mills DA; Furumoto EJ; Rolon ML; Fleming JA; Roberts RF
mSphere; 2021 Aug; 6(4):e0008421. PubMed ID: 34232082
[TBL] [Abstract][Full Text] [Related]
31. Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases.
Ashique S; De Rubis G; Sirohi E; Mishra N; Rihan M; Garg A; Reyes RJ; Manandhar B; Bhatt S; Jha NK; Singh TG; Gupta G; Singh SK; Chellappan DK; Paudel KR; Hansbro PM; Oliver BG; Dua K
Chem Biol Interact; 2022 Dec; 368():110231. PubMed ID: 36288778
[TBL] [Abstract][Full Text] [Related]
32. Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19.
Zhang F; Wan Y; Zuo T; Yeoh YK; Liu Q; Zhang L; Zhan H; Lu W; Xu W; Lui GCY; Li AYL; Cheung CP; Wong CK; Chan PKS; Chan FKL; Ng SC
Gastroenterology; 2022 Feb; 162(2):548-561.e4. PubMed ID: 34687739
[TBL] [Abstract][Full Text] [Related]
33. Higher Fecal Short-Chain Fatty Acid Levels Are Associated with Gut Microbiome Dysbiosis, Obesity, Hypertension and Cardiometabolic Disease Risk Factors.
de la Cuesta-Zuluaga J; Mueller NT; Álvarez-Quintero R; Velásquez-Mejía EP; Sierra JA; Corrales-Agudelo V; Carmona JA; Abad JM; Escobar JS
Nutrients; 2018 Dec; 11(1):. PubMed ID: 30591685
[TBL] [Abstract][Full Text] [Related]
34. Possible role of gut microbes and host's immune response in gut-lung homeostasis.
Rastogi S; Mohanty S; Sharma S; Tripathi P
Front Immunol; 2022; 13():954339. PubMed ID: 36275735
[TBL] [Abstract][Full Text] [Related]
35. Composition and dynamics of the respiratory tract microbiome in intubated patients.
Kelly BJ; Imai I; Bittinger K; Laughlin A; Fuchs BD; Bushman FD; Collman RG
Microbiome; 2016 Feb; 4():7. PubMed ID: 26865050
[TBL] [Abstract][Full Text] [Related]
36. Reduced fecal short-chain fatty acids levels and the relationship with gut microbiota in IgA nephropathy.
Chai L; Luo Q; Cai K; Wang K; Xu B
BMC Nephrol; 2021 Jun; 22(1):209. PubMed ID: 34082732
[TBL] [Abstract][Full Text] [Related]
37. Dysbiosis Across Multiple Body Sites in Critically Ill Adult Surgical Patients.
Yeh A; Rogers MB; Firek B; Neal MD; Zuckerbraun BS; Morowitz MJ
Shock; 2016 Dec; 46(6):649-654. PubMed ID: 27454385
[TBL] [Abstract][Full Text] [Related]
38. Gut microbiota profiles in critically ill patients, potential biomarkers and risk variables for sepsis.
Agudelo-Ochoa GM; Valdés-Duque BE; Giraldo-Giraldo NA; Jaillier-Ramírez AM; Giraldo-Villa A; Acevedo-Castaño I; Yepes-Molina MA; Barbosa-Barbosa J; Benítez-Paéz A
Gut Microbes; 2020 Nov; 12(1):1707610. PubMed ID: 31924126
[TBL] [Abstract][Full Text] [Related]
39. The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease.
Abdelbary MMH; Hatting M; Bott A; Dahlhausen A; Keller D; Trautwein C; Conrads G
Front Cell Infect Microbiol; 2022; 12():1010853. PubMed ID: 36275026
[TBL] [Abstract][Full Text] [Related]
40. Altered Gut Microbiota and Short-Chain Fatty Acids After Vonoprazan-Amoxicillin Dual Therapy for
Hu Y; Xu X; Ouyang YB; He C; Li NS; Xie C; Peng C; Zhu ZH; Shu X; Xie Y; Lu NH; Zhu Y
Front Cell Infect Microbiol; 2022; 12():881968. PubMed ID: 35719338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
